Gabrielle Mazero
Lawyers
Filters
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Kodiak Sciences $184 million stock offering
We advised the underwriters on the offering
Legence $364 million secondary offering
We advised the representatives of the several underwriters on the offering
Tenaya Therapeutics $60 million units offering
We advised the joint book-running managers and representatives of the several underwriters
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering
Immix Biopharma $100 million stock and pre-funded warrants offering
We advised the sole bookrunner and representative of the several underwriters on the offering
DXC Technology €650 million senior notes offering
We advised the initial purchasers on the investment-grade debt offering
Shift4 Payments €430 million notes offering
We advised the representative of the initial purchasers on the offering
Illumina $500 million notes offering
We advised the underwriters on the offering
OSI Systems $500 million convertible senior notes offering
We advised the representatives of the initial purchases on the offering